Advances in high-throughput sequencing technologies has drastically increased the efficiency to access different alterations in the genome, transcriptome, proteome, and epigenome of a cancer cell. This has increased the computational burden to analyze these “big data” making the translation of the knowledge into insightful and impactful patient outcomes extraordinarily challenging. Among these alterations, only a few “driver” alterations are expected to confer crucial growth advantage. These are greatly outnumbered by functionally inconsequential “passenger” alterations. This poses a significant challenge for the identification of driver alterations, requiring solutions to novel algorithmic problems. Although, the insight on driver alterat...
Recent advances in high-throughput genomic technologies and high-performance computing have propelle...
Human cancer is a complex and dynamic disease with mutational, spatial, and temporal heterogeneity. ...
Copy number amplifications and deletions that are recurrent in cancer samples harbor genes that conf...
The notion that DNA changes could drive the growth of cancer was first speculated more than a centur...
Identifying molecular cancer drivers is critical for precision oncology. Multiple advanced algorithm...
Cancer evolves due to changes in DNA that give a cell an advantage at the expense of the remaining o...
Identifying molecular cancer drivers is critical for precision oncology. Multiple advanced algorithm...
The transformation of a normal cell into a cancer cell involves the accumulation of somatic DNA alte...
Analysis of somatic alterations in cancer genomes has been accelerated through the rapid growth of t...
Over time, much has been done in attempt to understand the various causes and complex molecular mech...
The word “cancer” identifies a collection of remarkably diverse range of diseases whose common trait...
Cancer is a very complex genetic disease driven by combinations of mutated genes. This complexity st...
none3The recent improvement of the high-throughput sequencing technologies is having a strong impact...
Prioritizing molecular alterations that act as drivers of cancer remains a crucial bottleneck in the...
Notwithstanding decades of scientific and clinical investigation, cancer remains a disease that enda...
Recent advances in high-throughput genomic technologies and high-performance computing have propelle...
Human cancer is a complex and dynamic disease with mutational, spatial, and temporal heterogeneity. ...
Copy number amplifications and deletions that are recurrent in cancer samples harbor genes that conf...
The notion that DNA changes could drive the growth of cancer was first speculated more than a centur...
Identifying molecular cancer drivers is critical for precision oncology. Multiple advanced algorithm...
Cancer evolves due to changes in DNA that give a cell an advantage at the expense of the remaining o...
Identifying molecular cancer drivers is critical for precision oncology. Multiple advanced algorithm...
The transformation of a normal cell into a cancer cell involves the accumulation of somatic DNA alte...
Analysis of somatic alterations in cancer genomes has been accelerated through the rapid growth of t...
Over time, much has been done in attempt to understand the various causes and complex molecular mech...
The word “cancer” identifies a collection of remarkably diverse range of diseases whose common trait...
Cancer is a very complex genetic disease driven by combinations of mutated genes. This complexity st...
none3The recent improvement of the high-throughput sequencing technologies is having a strong impact...
Prioritizing molecular alterations that act as drivers of cancer remains a crucial bottleneck in the...
Notwithstanding decades of scientific and clinical investigation, cancer remains a disease that enda...
Recent advances in high-throughput genomic technologies and high-performance computing have propelle...
Human cancer is a complex and dynamic disease with mutational, spatial, and temporal heterogeneity. ...
Copy number amplifications and deletions that are recurrent in cancer samples harbor genes that conf...